Varicose Vein Treatment Market by Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation and Stripping), Product (sclerotherapy injection, Ablation devices and others) and End User (Hospitals, Clinics, and Ambulatory centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

February 2019 | 175 pages | ID: VD080BC669FEN
Allied Market Research

Abstracts

varicose vein treatment market overview:

The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025. Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.

Considerable rise in prevalence of varicose vein problem, surge in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, boost the growth of the market. Whereas, increase in level of awareness as well as development in the emerging markets create numerous opportunities in the varicose vein treatment market.

The global varicose vein treatment market is segmented based on procedure, product, end user, and region. Based on procedure, the market is endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product the market is segmented into ablation devices, sclerotherapy injection and others. Ablation devices is further divided into radiofrequency ablation devices, laser ablation devices and others. Based on end user, the market is divided into hospital, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits for varicose vein treatment market:

The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

varicose vein treatment Key Market Segments:

By Procedure

• Injection Sclerotherapy
• Endovenous Ablation
• Surgical Ligation/Stripping

By Product

• Sclerotherapy injection
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Others
• Others

By End User

• Hospitals
• Clinics
• Ambulatory centers

By Region

North America

• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Alma Lasers Ltd
• Angiodynamics, Inc
• Biolitec AG
• BTG PLC
• Energist Ltd
• Medtronic
• Lumenis
• Sciton Inc
• Syneron
• WONTECH Co., Ltd.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

• Teleflex
• The Vein Company
• F care Systems
• Miravas
• SharpLight Technologies

Contents

CHAPTER: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key Market Segments
  1.3.1. List of key players profiled in the report:
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. key findings
  3.2.1. Top investment pockets
  3.2.2. Top player positioning
3.3. Market dynamics
  3.3.1. Drivers
    3.3.1.1. Increasing geriatric population
    3.3.1.2. Advanced varicose vein treatment devices
    3.3.1.3. Engagement in occupation that increases the prevalence of varicose vein treatment
    3.3.1.4. Technological advancement
  3.3.2. Restraints
    3.3.2.1. Risk factors associated with the treatment devices and less experienced healthcare professionals
  3.3.3. Opportunities
    3.3.3.1. Increase in level of awareness
    3.3.3.2. Untapped markets in emerging markets
  3.3.4. Impact analysis

CHAPTER: 4: VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE

4.1. Overview
  4.1.1. Market size and forecast
4.2. Endovenous Ablation
  4.2.1. Key trends and opportunities
  4.2.2. Market size and forecast
  4.2.3. Market analysis, by country
4.3. Injection Sclerotherapy
  4.3.1. Key trends and opportunities
  4.3.2. Market size and forecast
  4.3.3. Market analysis, by country
4.4. Surgical Ligation/Stripping
  4.4.1. Key trends and opportunities
  4.4.2. Market size and forecast
  4.4.3. Market analysis, by country

CHAPTER: 5: VARICOSE VEIN TREATMENT MARKET, BY PRODUCT

5.1. Overview
  5.1.1. Market size and forecast
5.2. Ablation Devices
  5.2.1. Market size and forecast
  5.2.2. Market analysis, by country
    5.2.2.1. Radiofrequency Ablation Devices
    5.2.2.2. Laser ablation devices
    5.2.2.3. Others
  5.2.3. Sclerotherapy Injection
  5.2.4. Market size and forecast
  5.2.5. Market analysis, by country
  5.2.6. Others
  5.2.7. Market size and forecast
  5.2.8. Market analysis, by country

CHAPTER: 6: VARICOSE VEIN TREATMENT MARKET, BY END USER

6.1. Overview
  6.1.1. Market size and forecast
6.2. Hospitals
  6.2.1. Market size and forecast
  6.2.2. Market analysis, by country
6.3. Ambulatory Centers
  6.3.1. Market size and forecast
  6.3.2. Market analysis, by country
6.4. Clinics
  6.4.1. Market size and forecast
  6.4.2. Market analysis, by country

CHAPTER: 7: VARICOSE VEIN TREATMENT MARKET, BY REGION

7.1. Overview
  7.1.1. Market size and forecast
7.2. North America
  7.2.1. Key trends and opportunities
  7.2.2. North America market size & forecast, by country
    7.2.2.1. U.S. market size & forecast, by procedure
    7.2.2.2. U.S. market size & forecast, by product
    7.2.2.3. U.S. market size & forecast, by end user
    7.2.2.4. Canada market size & forecast, by procedure
    7.2.2.5. Canada market size & forecast, by product
    7.2.2.6. Canada market size & forecast, by end user
    7.2.2.7. Mexico market size & forecast, by procedure
    7.2.2.8. Mexico market size & forecast, by Product
    7.2.2.9. Mexico market size & forecast, by end user
  7.2.3. North America market size & forecast, by procedure
  7.2.4. North America market size & forecast, by product
  7.2.5. North America market size & forecast, by end user
7.3. Europe
  7.3.1. Key trends and opportunities
  7.3.2. Europe market size & forecast for varicose vein treatment market, by country
    7.3.2.1. Germany market size & forecast, by procedure
    7.3.2.2. Germany market size & forecast, by product
    7.3.2.3. Germany market size & forecast, by end user
    7.3.2.4. France market size & forecast, by Procedure
    7.3.2.5. France market size & forecast, by product
    7.3.2.6. France market size & forecast, by end user
    7.3.2.7. UK market size & forecast, by procedure
    7.3.2.8. UK market size & forecast, by product
    7.3.2.9. UK market size & forecast, by end user
    7.3.2.10. Italy market size & forecast, by procedure
    7.3.2.11. Italy market size & forecast, by product
    7.3.2.12. Italy market size & forecast, by end user
    7.3.2.13. Spain market size & forecast, by procedure
    7.3.2.14. Spain market size & forecast, by product
    7.3.2.15. Spain market size & forecast, by end user
    7.3.2.16. Rest of Europe market size & forecast, by procedure
    7.3.2.17. Rest of Europe market size & forecast, by product
    7.3.2.18. Rest of Europe market size & forecast, by end user
  7.3.3. Europe market size & forecast, by procedure
  7.3.4. Europe market size & forecast, by product
  7.3.5. Europe market size & forecast, by end user
7.4. Asia-Pacific
  7.4.1. Key trends and opportunities
  7.4.2. Asia-Pacific market size & forecast, by country
    7.4.2.1. Japan market size & forecast, by procedure
    7.4.2.2. Japan market size & forecast, by product
    7.4.2.3. Japan market size & forecast, by end user
    7.4.2.4. China market size & forecast, by procedure
    7.4.2.5. China market size & forecast, by product
    7.4.2.6. China market size & forecast, by end user
    7.4.2.7. India market size & forecast, by procedure
    7.4.2.8. India market size & forecast, by product
    7.4.2.9. India market size & forecast, by end user
    7.4.2.10. Australia market size & forecast, by procedure
    7.4.2.11. Australia market size & forecast, by product
    7.4.2.12. Australia market size & forecast, by end user
    7.4.2.13. South Korea market size & forecast, by procedure
    7.4.2.14. South Korea market size & forecast, by product
    7.4.2.15. South Korea market size & forecast, by end user
    7.4.2.16. Rest of Asia-Pacific market size & forecast, by procedure
    7.4.2.17. Rest of Asia-Pacific market size & forecast, by product
    7.4.2.18. Rest of Asia-Pacific market size & forecast, by end user
  7.4.3. Asia-Pacific market size & forecast, by procedure
  7.4.4. Asia-Pacific market size & forecast, by product
  7.4.5. Asia-Pacific market size & forecast, by end user
7.5. LAMEA
  7.5.1. Key trends and opportunities
  7.5.2. LAMEA market size & forecast, by country
    7.5.2.1. Brazil market size & forecast, by procedure
    7.5.2.2. Brazil market size & forecast, by product
    7.5.2.3. Brazil market size & forecast, by end user
    7.5.2.4. South Africa market size & forecast, by procedure
    7.5.2.5. South Africa market size & forecast, by product
    7.5.2.6. South Africa market size & forecast, by end user
    7.5.2.7. Saudi Arabia market size & forecast, by procedure
    7.5.2.8. Saudi Arabia market size & forecast, by product
    7.5.2.9. Saudi Arabia market size & forecast, by end user
    7.5.2.10. Rest of LAMEA market size & forecast, by procedure
    7.5.2.11. Rest of LAMEA market size & forecast, by product
    7.5.2.12. Rest of LAMEA market size & forecast, by end user
  7.5.3. LAMEA market size & forecast, by procedure
  7.5.4. LAMEA market size & forecast, by product
  7.5.5. LAMEA market size & forecast, by end user

CHAPTER: 8: COMPANY PROFILES

8.1. Angiodynamics Inc
  8.1.1. Company overview
  8.1.2. Company snapshot
  8.1.3. Operating business segments
  8.1.4. Product Portfolio
  8.1.5. Business performance
8.2. Alma Lasers
  8.2.1. Company overview
  8.2.2. Company snapshot
  8.2.3. Operating business segments
  8.2.4. Product portfolio
  8.2.5. Key strategic moves and developments
8.3. biolitec AG Untere Viaduktgasse
  8.3.1. Company overview
  8.3.2. Company snapshot
  8.3.3. Operating business segments
  8.3.4. Product portfolio
8.4. BTG International Ltd
  8.4.1. Company overview
  8.4.2. Company snapshot
  8.4.3. Operating business segments
  8.4.4. Product Portfolio
  8.4.5. Business performance
8.5. Energist Ltd
  8.5.1. Company overview
  8.5.2. Company snapshot
  8.5.3. Product Portfolio
8.6. Lumenis
  8.6.1. Company overview
  8.6.2. Company snapshot
  8.6.3. Operating business segments
  8.6.4. Product Portfolio
8.7. Medtronic
  8.7.1. Company overview
  8.7.2. Company snapshot
  8.7.3. Operating business segments
  8.7.4. Product portfolio
8.8. Sciton Inc
  8.8.1. Company overview
  8.8.2. Company snapshot
  8.8.3. Operating business segments
  8.8.4. Product Portfolio
8.9. Syneron Medical Ltd
  8.9.1. Company overview
  8.9.2. Company snapshot
  8.9.3. Operating business segments
  8.9.4. Product Portfolio
  8.9.5. Key strategic moves and developments
8.10. WON TECH Co., Ltd
  8.10.1. Company overview
  8.10.2. Company snapshot
  8.10.3. Operating business segments
  8.10.4. Product Portfolio

List Of Tables

LIST OF TABLES

TABLE 01. VARICOSE VEIN TREATMENT MARKET SEGMENTATION
TABLE 02. TOP INVESTMENT POCKETS
TABLE 03. TOP PLAYER POSITIONING, 2017
TABLE 04. IMPACT ANALYSIS
TABLE 05. GLOBAL VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 06. VARICOSE VEIN TREATMENT MARKET FOR ENDOVENOUS ABLATION, BY REGION, 2017-2025 ($MILLION)
TABLE 07. VARICOSE VEIN TREATMENT MARKET FOR INJECTION SCLEROTHERAPY, BY REGION, 2017–2025 ($MILLION)
TABLE 08. VARICOSE VEIN TREATMENT MARKET FOR SURGICAL LIGATION/STRIPPING, BY REGION, 2017–2025 ($MILLION)
TABLE 09. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 10. VARICOSE VEIN TREATMENT DEVICES MARKET FOR ABLATION DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 11. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET FOR PRODUCT, BY TYPE, 2017–2025 ($MILLION)
TABLE 12. VARICOSE VEIN TREATMENT DEVICES MARKET FOR VENOUS CLOSURE PRODUCTS, BY REGION, 2017–2025 ($MILLION)
TABLE 13. VARICOSE VEIN TREATMENT DEVICES MARKET FOR VENOUS CLOSURE PRODUCTS, BY REGION, 2017–2025 ($MILLION)
TABLE 14. GLOBAL VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 15. GLOBAL VARICOSE VEIN TREATMENT MARKET FOR HOSPITALS, BY REGION, 2017–2025 ($MILLION)
TABLE 16. GLOBAL VARICOSE VEIN TREATMENT FOR AMBULATORY CENTERS, BY REGION, 2017–2025 ($MILLION)
TABLE 17. GLOBAL VARICOSE VEIN TREATMENT MARKET FOR CLINICS, BY REGION, 2017–2025 ($MILLION)
TABLE 18. VARICOSE VEIN TREATMENT MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 19. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 20. U.S. VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 21. U.S. VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 22. U.S. VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 23. CANADA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 24. CANADA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 25. CANADA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 26. MEXICO VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 27. MEXICO VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 28. MEXICO VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 30. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 31. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 32. EUROPE VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 33. GERMANY VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 34. GERMANY VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 35. GERMANY VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 36. FRANCE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 37. FRANCE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 38. FRANCE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 39. UK VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 40. UK VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 41. UK VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 42. ITALY VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 43. ITALY VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 44. ITALY VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 45. SPAIN VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 46. SPAIN VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 47. SPAIN VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48. REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 49. REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 50. REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 51. EUROPE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 52. EUROPE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 53. EUROPE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 54. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 55. JAPAN VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 56. JAPAN VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 57. JAPAN VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 58. CHINA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 59. CHINA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 60. CHINA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 61. INDIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 62. INDIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 63. INDIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 64. AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 65. AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 66. AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 67. SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 68. SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 69. SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT PROCEDURE MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 73. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 74. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 75. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 76. LAMEA VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 77. BRAZIL VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 78. BRAZIL VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 79. BRAZIL VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 80. SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 81. SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 82. SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 83. SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 84. SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 85. SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 86. REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 87. REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 88. REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 89. LAMEA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 90. LAMEA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 91. LAMEA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 92. ANGIODYNAMICS INC: COMPANY SNAPSHOT
TABLE 93. ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 94. ANGIODYNAMICS INC: PRODUCT PORTFOLIO
TABLE 95. ALMA LASERS: COMPANY SNAPSHOT
TABLE 96. ALMA LASERS: PRODUCT PORTFOLIO
TABLE 97. BIOLITEC AG: COMPANY SNAPSHOT
TABLE 98. BIOLITEC AG: OPERATING SEGMENTS
TABLE 99. BIOLITEC AG: PRODUCT PORTFOLIO
TABLE 100. BTG PLC: COMPANY SNAPSHOT
TABLE 101. BTG PLC: PRODUCT CATEGORY SEGMENTS
TABLE 102. BTG PLC: PRODUCT PORTFOLIO
TABLE 103. ENERGIST LTD: COMPANY SNAPSHOT
TABLE 104. ENERGIST LTD: PRODUCT PORTFOLIO
TABLE 105. LUMENIS.: COMPANY SNAPSHOT
TABLE 106. LUMENIS: PRODUCT PORTFOLIO
TABLE 107. MEDTRONIC: COMPANY SNAPSHOT
TABLE 108. MEDTRONIC: PRODUCT CATEGORIES
TABLE 109. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 110. SCITON INC: COMPANY SNAPSHOT
TABLE 111. SCITON INC: OPERATING SEGMENTS
TABLE 112. SCITON INC: PRODUCT PORTFOLIO
TABLE 113. SYNERON MEDICAL: COMPANY SNAPSHOT
TABLE 114. SYNERON MEDICAL: PRODUCT CATEGORIES
TABLE 115. SYNERON MEDICAL: PRODUCT PORTFOLIO
TABLE 116. WONTECH CO. LTD: COMPANY SNAPSHOT
TABLE 117. WONTECH CO. LTD: OPERATING SEGMENTS
TABLE 117. WONTECH CO. LTD: PRODUCT PORTFOLIO

List Of Figures

LIST OF FIGURES

FIGURE 01. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR ENDOVENOUS ABLATION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 02. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR SCLEROTHERAPY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 03. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR SURGICAL LIGATION/STRIPPING, BY COUNTRY, 2017 & 2025 (%)
FIGURE 04. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT DEVICES MARKET FOR ABLATION DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT DEVICES MARKET FOR SCLEROTHERAPY INJECTION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT DEVICES MARKET FOR SCLEROTHERAPY INJECTION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR AMBULATORY CENTERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR CLINICS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10. ANGIODYNAMICS INC: REVENUE, 2016–2018 ($MILLION)
FIGURE 11. ANGIODYNAMICS INC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 12. ANGIODYNAMICS INC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 13. BTG PLC: NET SALES, 2015–2017 ($MILLION)
FIGURE 14. BTG PLC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 15. BTG PLC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 16. LUMENIS.: OPERATING SEGMENTS
FIGURE 17. MEDTRONIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 18. MEDTRONIC: REVENUE SHARE BY REGION, 2017 (%)